Skip to main content

Web Exclusives

Enhertu First FDA-Approved Drug for HER2-Positive Non–Small-Cell Lung Cancer

Lytgobi FDA Approved for Intrahepatic Cholangiocarcinoma with FGFR2 Fusion

Conference Highlights ASCO

Trastuzumab Deruxtecan a New Standard for Patients with HER2-Low Metastatic Breast Cancer

Breyanzi Now FDA Approved for Second-Line Treatment of Large B-Cell Lymphoma

Conference Highlights ASCO

Black Patients with Cancer and COVID-19 More Likely Than White Patients to Have Therapy Disruptions

Conference Highlights ASCO

PD-1 Inhibition with Dostarlimab Led to Remission in All Patients with Mismatch Repair-Deficient Rectal Cancer

Tafinlar plus Mekinist First Tumor-Agnostic Therapy Approved for Any Unresectable or Metastatic Solid Tumors with BRAF Mutation

Xalkori Now FDA Approved for the Treatment of ALK-Positive Inflammatory Myofibroblastic Tumor

Oncologists’ Common Misconceptions About Biosimilars Revealed in a Recent Survey

Infectious Diseases

Peptide-Based CoVac-1 Vaccine Shows Promise Against COVID-19 in Patients with Cancer

Page 8 of 37
Results 71 - 80 of 362